MedPath

Potassium

Generic Name
Potassium
Drug Type
Small Molecule
Chemical Formula
K
CAS Number
7440-09-7
Unique Ingredient Identifier
RWP5GA015D
Background

Potassium is an essential nutrient, like Calcium and Magnesium. It was identified as a shortfall nutrient by the 2015-2020 Advisory Committee of Dietary Guidelines for Americans. Many conditions and diseases interfere with normal body potassium balance, and underconsumption of potassium is one example. Hypokalemia (low potassium) or hyperkalemia (high potassium) may result, manifesting as various signs and symptoms. Some examples of potassium-related complications include life-threatening arrhythmia, neuromuscular dysfunction, diarrhea, nausea, and vomiting.

Various pharmacological preparations have been formulated to replenish potassium. They are available in an assortment of tablet, injection, and other forms, depending on the setting and condition being treated. Potassium is often a key ingredient for intravenous fluids, given to patients in clinical settings for rehydration, nutrition, and replenishment of electrolytes. Examples of potassium formulations include potassium citrate, potassium chloride, and potassium with dextrose and sodium chloride.

Indication

General uses of potassium

Potassium is indicated to treat a variety of conditions. Firstly, it used to replenish potassium that has been depleted by conditions including but not limited to malabsorption, decreased intake, or excess sodium intake. The causes of potassium deficiency are numerous. The following indications for potassium are not comprehensive, but include the main indications for which this nutrient is used. Various products and preparations contain potassium.

Potassium chloride

Potassium chloride is one of the main preparations of potassium used in a clinical setting. The oral solution is indicated for the prevention and treatment of hypokalemia presenting with or without metabolic alkalosis, in patients who have failed conservative management with potassium-rich foods or diuretic dose titrations. The injection form of potassium chloride is indicated to replenish potassium in patients who are not feasible candidates for oral potassium. Highly concentrated potassium is intended for the treatment of potassium deficiency in fluid restricted individuals who cannot tolerate fluid volumes normally associated with injected potassium solutions that contain lower concentrations.

Finally, the extended-release tablet preparation of potassium chloride is used to treat hypokalemia with or without metabolic alkalosis, to treat digitalis intoxication, and to manage patients with hypokalemic familial periodic paralysis. It is also used in the prevention of hypokalemia in those who are at a high risk of negative clinical outcomes if hypokalemia occurs; patients on digitalis or those with cardiac arrhythmias would be at particular risk of negative outcomes.

Potassium chloride with dextrose and sodium chloride

This liquid preparation is is indicated in a clinical setting as a source of water, calories and electrolytes. Potassium acetate solution is meant as an alternative to potassium chloride, replenishing potassium and added to large volume infusion fluids for intravenous injection.

Potassium citrate

The potassium citrate preparation is used for the management of renal tubular acidosis (RTA) with calcium stones (nephrolithiasis); calcium oxalate stones by any cause, and uric acid nephrolithiasis (with or without calcium stones). This regimen also includes adequate water intake (leading to a urine out put of 2 L/day or more) and sodium restriction.

Associated Conditions
Caloric Intake, Electrolyte and fluid balance conditions, Hydration, Hypokalemia, Potassium

Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults

Phase 4
Conditions
Helicobacter Pylori Infection
Interventions
First Posted Date
2018-11-05
Last Posted Date
2018-11-05
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
60
Registration Number
NCT03730766
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy

First Posted Date
2018-10-17
Last Posted Date
2019-12-10
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
112
Registration Number
NCT03708848
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori

First Posted Date
2018-09-28
Last Posted Date
2021-10-26
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
360
Registration Number
NCT03688828
Locations
🇨🇳

Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, Hubei, China

Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern

Not Applicable
Conditions
Chronic Kidney Disease Patients
Interventions
First Posted Date
2018-07-27
Last Posted Date
2018-07-27
Lead Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
189
Registration Number
NCT03603938
Locations
🇨🇳

The fifth affiliated hospital of Sun Yat-sen university, Zhuhai, Guangdong, China

The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD

Not Applicable
Conditions
Chronic Kidney Disease
Interventions
First Posted Date
2018-07-27
Last Posted Date
2018-07-27
Lead Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
252
Registration Number
NCT03604003

Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective

Phase 1
Conditions
ADHD
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-06-20
Last Posted Date
2018-06-20
Lead Sponsor
AlkaliDx, Inc.
Target Recruit Count
100
Registration Number
NCT03563573
Locations
🇺🇸

Clinical Research Center of New Jersey (CRCNJ), Voorhees, New Jersey, United States

High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment

Phase 4
Completed
Conditions
Helicobacter Pylori Infection
Interventions
First Posted Date
2018-06-15
Last Posted Date
2019-06-18
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
216
Registration Number
NCT03557437
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Completed
Conditions
Atrial Fibrillation
Interventions
First Posted Date
2018-03-12
Last Posted Date
2018-03-12
Lead Sponsor
Bayer
Target Recruit Count
249
Registration Number
NCT03462446

Effect of Laser and Potassium Nitrate Application on the Sensitivity Control in Bleached Teeth

Phase 1
Completed
Conditions
Dentin Sensitivity
Interventions
Drug: In-office dental bleaching
Drug: Low Level Laser Therapy
First Posted Date
2018-02-15
Last Posted Date
2018-02-15
Lead Sponsor
Universidade Federal do Para
Target Recruit Count
50
Registration Number
NCT03434782
Locations
🇧🇷

Brennda Lucy Freitas de Paula, Belem, Para, Brazil

Tailored Therapy for Helicobacter Pylori Rescue Treatment

First Posted Date
2018-01-29
Last Posted Date
2018-08-07
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
200
Registration Number
NCT03413020
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath